Your browser doesn't support javascript.
loading
Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials?
Cross, Gail B; O' Doherty, Jim; Chang, Christina C; Kelleher, Anthony D; Paton, Nicholas I.
Affiliation
  • Cross GB; Immunovirology and Pathogenesis Program, The Kirby Institute, UNSW, Sydney.
  • O' Doherty J; Burnet Institute, Victoria, Australia.
  • Chang CC; Siemens Medical Solutions, Malvern, PA.
  • Kelleher AD; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.
  • Paton NI; Radiography & Diagnostic Imaging, University College Dublin, Dublin, Ireland.
J Infect Dis ; 229(4): 1229-1238, 2024 Apr 12.
Article in En | MEDLINE | ID: mdl-37788578
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Positron Emission Tomography Computed Tomography Limits: Humans Language: En Journal: J Infect Dis Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Positron Emission Tomography Computed Tomography Limits: Humans Language: En Journal: J Infect Dis Year: 2024 Document type: Article Country of publication: